Can AI replace 60% of pharmaceutical r&d by designing and testing new drugs in silico using generative chemistry and predictive toxicity models ?
Cast your vote — then read what our editor and the AI models found.
Deep learning models like AlphaFold have already revolutionized protein folding. Generative AI is now proposing novel molecules with promising binding affinities—raising the question of when AI can fully take over drug discovery.
Status last checked on May 10, 2026.
Gallery
Disagree? Post your comment below.
What the audience thinks
0 votesDiscussion
no commentsMore in technology
Can AI design and deploy a fully autonomous swarm of medical nanobots that can perform micro-surgery inside human arteries without any human oversight ?
Can AI replace every human scientist in a top-tier lab with ai agents capable of designing and conducting breakthrough experiments in chemistry physics or medicine ?
Can AI hold a grudge for forty years and let it go ?